Daniel B. Drachman

Affiliations: 
Johns Hopkins University School of Medicine, Baltimore, MD, United States 
Area:
Neuromuscular diseases, myathenia gravis, trophic regulation of muscle
Google:
"Daniel Drachman"
Mean distance: 13.34 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Drachman DB, Kaminski HJ. (2014) Neuromuscular junction as Achilles' heel: yet another autoantibody? Neurology. 82: 1942-3
Sun W, Adams RN, Miagkov A, et al. (2012) Specific immunotherapy of experimental myasthenia gravis in vitro and in vivo: the Guided Missile strategy. Journal of Neuroimmunology. 251: 25-32
Casciola-Rosen L, Miagkov A, Nagaraju K, et al. (2008) Granzyme B: evidence for a role in the origin of myasthenia gravis. Journal of Neuroimmunology. 201: 33-40
Drachman DB. (2008) Therapy of myasthenia gravis. Handbook of Clinical Neurology. 91: 253-72
Drachman DB, Adams RN, Hu R, et al. (2008) Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis. Annals of the New York Academy of Sciences. 1132: 305-14
Zhou L, McConville J, Chaudhry V, et al. (2004) Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients. Muscle & Nerve. 30: 55-60
Drachman DB, Wu JM, Miagkov A, et al. (2003) Specific immunotherapy of experimental myasthenia by genetically engineered APCs: the "guided missile" strategy. Annals of the New York Academy of Sciences. 998: 520-32
Miagkov A, Lobito AA, Yang B, et al. (2003) Production and characterization of a T cell receptor transgenic mouse recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor. Annals of the New York Academy of Sciences. 998: 379-83
Drachman DB. (2003) Autonomic "myasthenia": the case for an autoimmune pathogenesis. The Journal of Clinical Investigation. 111: 797-9
Drachman DB, Jones RJ, Brodsky RA. (2003) Treatment of refractory myasthenia: "rebooting" with high-dose cyclophosphamide. Annals of Neurology. 53: 29-34
See more...